바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.83 No.3
Citation Share

Tuberculosis Surveillance and Monitoring under the National Public-Private Mix Tuberculosis Control Project in South Korea 2016–2017

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2020, v.83 no.3, pp.218-227
https://doi.org/10.4046/trd.2020.0016
Jinsoo Min (The Catholic University of Korea)
Hyung Woo Kim (The Catholic University of Korea)

Jee Youn Oh (Korea University)
Ji Young Kang (The Catholic University of Korea)
Joosun Lee (Korea Centers for Disease Control and Prevention)
Young Joon Park (Korea Centers for Disease Control and Prevention)
Sung-Soon Lee (Inje University)

Ju Sang Kim (The Catholic University of Korea)
Jinsoo, M. , Hyung, W. K. , Jee, Y. O. , Ji, Y. K. , Joosun, L. , Young, J. P. , Sung-Soon, L. , & Ju, S. K. (2020). Tuberculosis Surveillance and Monitoring under the National Public-Private Mix Tuberculosis Control Project in South Korea 2016–2017. Tuberculosis & Respiratory Diseases, 83(3), 218-227, https://doi.org/10.4046/trd.2020.0016
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: The national Public-Private Mix (PPM) tuberculosis (TB) control project provides for the comprehensive management of TB patients at private hospitals in South Korea. Surveillance and monitoring of TB under the PPM project are essential toward achieving TB elimination goals. Methods: TB is a nationally notifiable disease in South Korea and is monitored using the surveillance system. The Korea Centers for Disease Control and Prevention quarterly generates monitoring indicators for TB management, used to evaluate activities of the PPM hospitals by the central steering committee of the national PPM TB control project. Based on the notification date, TB patients at PPM hospitals were enrolled in each quarter, forming a cohort, and followed up for at least 12 months to identify treatment outcomes. This report analyzed the dataset of cohorts the first quarter of 2016 through the fourth quarter of 2017. Results: The coverage of sputum, smear, and culture tests among the pulmonary TB cases were 92.8% and 91.5%, respectively. The percentage of positive sputum smear and culture test results were 30.7% and 61.5%, respectively. The coverage of drug susceptibility tests among the culture-confirmed cases was 92.8%. The treatment success rate among the smear-positive drug-susceptible cases was 83.2%. The coverage of latent TB infection treatment among the childhood TB contacts was significantly higher than that among the adult contacts (85.6% vs. 56.0%, p=0.001). Conclusion: This is the first official report to analyze monitoring indicators, describing the current status of the national PPM TB control project. To sustain its effect, strengthening the monitoring and evaluation systems is essential.

keywords
Public-Private Mix, Monitoring, Evaluation, Performance, Indicators

Reference

1.

1. Reid MJ, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, et al. Building a tuberculosis-free world: the Lancet Commission on tuberculosis. Lancet 2019;393:1331-84.

2.

2. Uplekar M. Public-private mix for tuberculosis care and prevention. What progress? What prospects? Int J Tuberc Lung Dis 2016;20:1424-9.

3.

3. Uplekar M. Involving private health care providers in delivery of TB care: global strategy. Tuberculosis (Edinb) 2003;83:156-64.

4.

4. Kwon S. Thirty years of national health insurance in South Korea: lessons for achieving universal health care coverage. Health Policy Plan 2009;24:63-71.

5.

5. Park JS. Increasing the treatment success rate of tuberculosis in a private hospital through Public-Private Mix (PPM) project. Tuberc Respir Dis 2011;70:143-9.

6.

6. Hong YP, Kim SJ, Lee EG, Lew WJ, Bai JY. Treatment of bacillary pulmonary tuberculosis at the chest clinics in the private sector in Korea, 1993. Int J Tuberc Lung Dis 1999;3:695-702.

7.

7. Kim HJ, Bai GH, Kang MK, Kim SJ, Lee JK, Cho SI, et al. A public-private collaboration model for treatment intervention to improve outcomes in patients with tuberculosis in the private sector. Tuberc Respir Dis 2009;66:349-57.

8.

8. Go U, Park M, Kim UN, Lee S, Han S, Lee J, et al. Tuberculosis prevention and care in Korea: Evolution of policy and practice. J Clin Tuberc Other Mycobact Dis 2018;11:28-36.

9.

9. Korea Centers for Disease Control and Prevention. Annual report on the notified tuberculosis in Korea. Cheongju: Korea Centers for Disease Control and Prevention; 2018.

10.

10. Korea Centers for Disease Control and Prevention. Tuberculosis surveillance newsletter [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2020 [cited 2020Mar 28]. Available from: http://tbzero.cdc.go.kr.

11.

11. Uplekar M, Lönnroth K; Stop TB Partnership, World Health Organization. Engaging all health care providers in TB control:guidance on implementing public-private mix approaches. Geneva: World Health Organization; 2006.

12.

12. Kang HY, Yoo H, Park W, Go U, Jeong E, Jung KS, et al. Tuberculosis Notification Completeness and Timeliness in the Republic of Korea During 2012-2014. Osong Public Health Res Perspect 2016;7:320-6.

13.

13. World Health Organization. Definitions and reporting framework for tuberculosis: 2013 revision. 2013, Geneva: World Heatlh Organization; 2013.

14.

14. Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 3rd ed. Cheongju:Korea Centers for Disease Control and Prevention; 2017.

15.

15. Cho KS. Tuberculosis control in the Republic of Korea. Epidemiol Health 2018;40:e2018036.

16.

16. The Global Fund to Fight AIDS, Tuberculosis and Malaria. Monitoring and evaluation toolkit. 4th ed. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria; 2011.

17.

17. Mngomezulu N, Cameron D, Olorunju S, Luthuli T, Dunbar R, Naidoo P. Reasons for the low bacteriological coverage of tuberculosis reported in Mpumalanga Province, South Africa. Public Health Action 2015;5:122-6.

18.

18. Kim CK, Choi SW, Park MS. Utilization of laboratory tests for tuberculosis and mycobacterial disease in Korea. Osong Public Health Res Perspect 2014;5(Suppl):S24-9.

19.

19. McCarthy KD, Metchock B, Kanphukiew A, Monkongdee P, Sinthuwattanawibool C, Tasaneeyapan T, et al. Monitoring the performance of mycobacteriology laboratories: a proposal for standardized indicators. Int J Tuberc Lung Dis 2008;12:1015-20.

20.

20. Min J, Shin YM, Lee WJ, Truong TT, Kang ES, An JY, et al. Clinical features of octogenarian patients with tuberculosis at a tertiary hospital in South Korea. J Int Med Res 2019;47:271-80.

21.

21. Kim H, Mok JH, Kang B, Lee T, Lee HK, Jang HJ, et al. Trend of multidrug and fluoroquinolone resistance in Mycobacterium tuberculosis isolates from 2010 to 2014 in Korea: a multicenter study. Korean J Intern Med 2019;34:344-52.

22.

22. Kwak N, Kim HR, Yoo CG, Kim YW, Han SK, Yim JJ. Multidrug-resistant tuberculosis over 20 years at a referral hospital in South Korea: trends and outcomes. Int J Tuberc Lung Dis 2019;23:174-80.

23.

23. Min J, Kim JS, Kim HW, Shin AY, Koo HK, Lee SS, et al. Clinical profiles of early and tuberculosis-related mortality in South Korea between 2015 and 2017: a cross-sectional study. BMC Infect Dis 2019;19:735.

24.

24. Min J, Kim JS. Diagnosis and treatment of latent tuberculosis infection. J Korean Med Assoc 2019;62:11-7.

25.

25. Getahun H, Matteelli A, Abubakar I, Hauer B, Pontali E, Migliori GB. Advancing global programmatic management of latent tuberculosis infection for at risk populations. Eur Respir J 2016;47:1327-30.

26.

26. Katsuda N, Hirosawa T, Reyer JA, Hamajima N. Roles of Public Health Centers (Hokenjo) in Tuberculosis Control in Japan. Nagoya J Med Sci 2015;77:19-28.

27.

27. Local Government Association. Tackling tuberculosis: local government’s public health role. London: Local Government Association, Public Health England; 2018.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy